Skip to main content

Peer Review reports

From: Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database

Original Submission
1 Nov 2024 Submitted Original manuscript
30 Nov 2024 Reviewed Reviewer Report - Yumei Wei
4 Dec 2024 Reviewed Reviewer Report
16 Feb 2025 Author responded Author comments - Bo Wei
Resubmission - Version 2
16 Feb 2025 Submitted Manuscript version 2
Publishing
18 Feb 2025 Editorially accepted
21 Feb 2025 Article published 10.1186/s40360-025-00872-9

You can find further information about peer review here.

Back to article page